SNORA24: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORA24

NCBI ID: G677809

SNORA24

Other Name(s): small nucleolar RNA, H/ACA box 24 | Small nucleolar RNA, H/ACA box 24 | ACA24 | SNORA24A

SNORA24: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Small nucleolar RNA (snRNA) is a class of non-coding RNAs that play a critical role in the regulation of gene expression in eukaryotic cells. One of the key functional SNORAs is H/ACA box 24 (H/ACA-24), which is a conserved RNA structure that is present in all eukaryotic cells. H/ACA-24 is involved in the regulation of various cellular processes, including DNA replication, transcription, and translation.

Recent studies have identified SNORA24 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and systemic inflammatory diseases. In this article, we will provide an overview of SNORA24, its functions, and potential as a drug target and biomarker.

Functions of SNORA24

SNORA24 is a small RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. It is composed of 19 amino acids and has a calculated molecular weight of 23 kDa. SNORA24 is expressed in various tissues and cells and is involved in various cellular processes, including:

1. DNA replication: SNORA24 is involved in the regulation of DNA replication, where it plays a role in the initiation of DNA replication by binding to the complex required for the initiation complex.
2. Transcription: SNORA24 is involved in the regulation of gene expression by binding to the RNA polymerase II complex. It has been shown to play a role in the regulation of gene expression in various tissues and cells, including brain, heart, and muscle.
3. Translation: SNORA24 is involved in the regulation of protein translation by binding to the 26S ribosome. It has been shown to play a role in the regulation of protein synthesis in various tissues and cells.
4. Cellular signaling: SNORA24 is involved in cellular signaling by regulating various signaling pathways, including the regulation of cell adhesion, the G1/S transition, and the DNA damage response.

Potential as a Drug Target

SNORA24 has been identified as a potential drug target due to its various functions in cellular signaling. SNORA24 has been shown to play a role in the regulation of cell adhesion, which is a critical process for the maintenance of tissue structure and function. It has also has been shown to play a role in the regulation of the G1/S transition, which is the process by which cells transition from the G1 phase to the S phase of the cell cycle.

In addition, SNORA24 has been shown to play a role in the regulation of cellular signaling pathways, including the regulation of cell adhesion, the G1/S transition, and the DNA damage response. These signaling pathways are critical for the regulation of various cellular processes , including cell growth, apoptosis, and inflammation.

Potential as a Biomarker

SNORA24 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and systemic inflammatory diseases. The regulation of SNORA24 has been shown to be altered in various diseases, including cancer, neurodegenerative diseases, and systemic inflammatory diseases.

Studies have shown that SNORA24 is overexpressed or underexpressed in various diseases, including cancer, neurodegenerative diseases, and systemic inflammatory diseases. Overexpression of SNORA24 has been shown to promote the growth and survival of cancer cells, while underexpression has been shown to negatively impact the growth and survival of cancer cells.

In addition, studies have shown that SNORA24 is involved in the regulation of cellular signaling pathways, including the regulation of cell adhesion, the G1/S transition, and the DNA damage response. These signaling pathways are

Protein Name: Small Nucleolar RNA, H/ACA Box 24

The "SNORA24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets